HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ken-ichi Hirata Selected Research
Ken-ichi Hirata Research Topics
Disease
25
Atherosclerosis
12/2014 - 01/2002
10
Heart Failure
09/2015 - 08/2007
10
Thrombosis (Thrombus)
04/2015 - 05/2009
10
Inflammation (Inflammations)
11/2014 - 01/2003
9
Neointima
05/2016 - 11/2005
8
Myocardial Infarction
09/2015 - 06/2007
8
Coronary Artery Disease (Coronary Atherosclerosis)
06/2015 - 11/2002
7
Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2015 - 08/2007
7
Cardiovascular Diseases (Cardiovascular Disease)
01/2013 - 12/2002
5
Stroke (Strokes)
09/2015 - 12/2002
5
Atherosclerotic Plaque (Atheroma)
06/2015 - 01/2002
4
Hypertension (High Blood Pressure)
03/2014 - 12/2002
4
Stable Angina
08/2012 - 12/2006
4
Acute Coronary Syndrome
07/2010 - 01/2002
3
Diabetes Mellitus
08/2015 - 05/2013
3
Dyslipidemias (Dyslipidemia)
06/2015 - 01/2013
3
Hyperplasia
01/2014 - 11/2005
3
Fibrosis (Cirrhosis)
04/2013 - 12/2002
3
Hypercholesterolemia
01/2011 - 01/2002
2
Pulmonary Hypertension
09/2015 - 01/2015
2
Hypoxia (Hypoxemia)
09/2015 - 11/2014
2
Cardiomyopathies (Cardiomyopathy)
09/2015 - 03/2010
2
Aneurysm (Aneurysms)
04/2015 - 10/2003
2
Pulmonary Arterial Hypertension
11/2014 - 01/2013
2
Cardiotoxicity
08/2014 - 03/2010
2
Prolapse
09/2013 - 11/2010
2
Cardiomegaly (Heart Hypertrophy)
05/2013 - 09/2002
2
Vascular Remodeling
01/2012 - 11/2005
2
Fabry Disease (Fabry's Disease)
08/2009 - 01/2009
2
Angina Pectoris
10/2005 - 11/2002
1
Right Ventricular Hypertrophy
09/2015
1
Hyperemia
09/2015
1
Atrioventricular Block
09/2015
1
AIDS-Related Complex (ARC)
06/2015
1
Hypoglycemia (Reactive Hypoglycemia)
06/2015
Drug/Important Bio-Agent (IBA)
7
Lipase (Acid Lipase)
FDA Link
05/2013 - 10/2004
5
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
08/2015 - 12/2002
5
Lipids
IBA
06/2015 - 12/2002
5
Cholesterol
IBA
04/2014 - 12/2002
5
Reactive Oxygen Species (Oxygen Radicals)
IBA
03/2014 - 01/2002
5
Apolipoproteins
IBA
06/2013 - 06/2002
4
Endothelin-1 (Endothelin 1)
IBA
09/2015 - 04/2009
4
LDL Receptors (LDL Receptor)
IBA
04/2014 - 05/2009
4
Dobutamine
FDA Link
Generic
04/2014 - 10/2007
4
oxidized low density lipoprotein
IBA
03/2011 - 11/2002
4
Superoxides (Superoxide)
IBA
09/2008 - 11/2002
3
Atrial Natriuretic Factor (ANF)
IBA
09/2015 - 09/2002
3
Messenger RNA (mRNA)
IBA
08/2015 - 09/2002
3
Oxidoreductases (Dehydrogenase)
IBA
08/2015 - 11/2002
3
Endothelins (Endothelin)
IBA
11/2014 - 03/2010
3
pitavastatin (itavastatin)
FDA Link
01/2013 - 07/2010
3
omega-Chloroacetophenone (Mace)
IBA
01/2013 - 10/2010
3
C-Reactive Protein
IBA
01/2011 - 12/2006
3
Enzymes
IBA
08/2009 - 01/2002
3
Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
IBA
04/2009 - 01/2002
3
Antioxidants
IBA
10/2007 - 01/2002
3
Nitric Oxide Synthase (NO Synthase)
IBA
08/2007 - 08/2002
3
NADPH Oxidases (NAD(P)H oxidase)
IBA
10/2005 - 11/2002
2
Interleukin-6 (Interleukin 6)
IBA
09/2015 - 11/2014
2
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
09/2015 - 11/2014
2
Semaxinib (SU5416)
IBA
09/2015 - 11/2014
2
Coenzyme A (CoA)
IBA
08/2015 - 01/2003
2
Fibrin
IBA
08/2015 - 01/2014
2
Glucose (Dextrose)
FDA Link
Generic
06/2015 - 07/2012
2
Aldosterone
IBA
04/2015 - 03/2014
2
Fatty Acids (Saturated Fatty Acids)
IBA
04/2015 - 05/2013
2
Toll-Like Receptors (Toll-Like Receptor)
IBA
04/2015 - 12/2006
2
Angiotensin II
IBA
04/2015 - 06/2006
2
Eicosapentaenoic Acid
IBA
12/2014 - 09/2011
2
Albumins
IBA
03/2014 - 05/2009
2
Phenobarbital (Luminal)
FDA Link
11/2013 - 11/2005
2
Nectins
IBA
06/2013 - 10/2009
2
HDL Cholesterol
IBA
05/2013 - 06/2007
2
Calcium
IBA
08/2012 - 01/2004
2
Proteoglycans (Proteoglycan)
IBA
03/2011 - 06/2003
2
Lipoproteins (Lipoprotein)
IBA
03/2011 - 06/2003
2
Adiponectin
IBA
07/2010 - 01/2008
2
Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)
IBA
09/2008 - 09/2002
2
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
11/2007 - 01/2002
2
Adrenergic Agents (Adrenergic Drugs)
IBA
10/2007 - 09/2002
2
Angiotensin II Type 1 Receptor Blockers
IBA
06/2006 - 10/2003
2
NAD (NADH)
IBA
10/2003 - 11/2002
2
cerivastatin (Kazak)
FDA Link
01/2003 - 12/2002
2
Nitric Oxide (Nitrogen Monoxide)
FDA Link
09/2002 - 08/2002
2
Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
IBA
06/2002 - 01/2002
1
Adenosine Triphosphate (ATP)
IBA
09/2015
1
Nitroprusside (Sodium Nitroprusside)
FDA Link
Generic
09/2015
1
Alkaline Phosphatase
IBA
08/2015
1
Streptozocin (Streptozotocin)
FDA Link
08/2015
Therapy/Procedure
15
Stents
05/2016 - 04/2007
9
Therapeutics
06/2015 - 02/2011
3
Cardiac Resynchronization Therapy
09/2015 - 08/2009
3
Intravenous Infusions
09/2015 - 10/2007
3
Drug-Eluting Stents
07/2014 - 10/2010
3
Renal Dialysis (Hemodialysis)
07/2014 - 01/2009
2
Defibrillators (Defibrillator)
01/2014 - 08/2009
2
Percutaneous Coronary Intervention
09/2013 - 04/2012
2
Ligation
01/2012 - 04/2009
1
Catheters
09/2015
1
Lasers (Laser)
04/2015